Jump Financial, LLC Tenaya Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.93 - $3.99 $41,975 - $86,778	-21,749 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$2.72 - $4.99 $59,157 - $108,527	21,749 New	21,749 $67,000
Q3 2023 Oct 21, 2024	SELL	$2.55 - $5.65 $19,635 - $43,505	-7,700 Reduced 34.53%	14,600 $37,000
Q3 2023 Nov 07, 2023	SELL	$2.55 - $5.65 $19,635 - $43,505	-7,700 Reduced 34.53%	14,600 $37,000
Q2 2023 Oct 21, 2024	BUY	$2.64 - $7.64 $1,454 - $4,209	551 Added 2.53%	22,300 $130,000
Q2 2023 Aug 07, 2023	BUY	$2.64 - $7.64 $58,872 - $170,372	22,300 New	22,300 $130,000
Q3 2022 Nov 07, 2022	BUY	$2.9 - $5.88 $60,320 - $122,304	20,800 New	20,800 $60,000

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $68.7M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.